Runx2 and Polycystins in Bone Mechanotransduction: Challenges for Therapeutic Opportunities
International Journal of Molecular Sciences · 13.05.2024 · 25 (10) · 5291
DOI: 10.3390/ijms25105291 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.05.2024. Verfasst von Antonios N Gargalionis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Biochemistry, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Ath…. Hauptthemen laut MEDLINE: Mechanotransduction, Cellular, Core Binding Factor Alpha 1 Subunit, TRPP Cation Channels. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bone mechanotransduction is a critical process during skeletal development in embryogenesis and organogenesis. At the same time, the type and level of mechanical loading regulates bone remodeling throughout the adult life. The aberrant mechanosensing of bone cells has been implicated in the development and progression of bone loss disorders, but also in the bone-specific aspect of other clinical entities, such as the tumorigenesis of solid organs. Novel treatment options have come into sight that exploit the mechanosensitivity of osteoblasts, osteocytes, and chondrocytes to achieve efficient bone regeneration. In this regard, runt-related transcription factor 2 (Runx2) has emerged as a chief skeletal-specific molecule of differentiation, which is prominent to induction by mechanical stimuli. Polycystins represent a family of mechanosensitive proteins that interact with Runx2 in mechano-induced signaling cascades and foster the regulation of alternative effectors of mechanotransuction. In the present narrative review, we employed a PubMed search to extract the literature concerning Runx2, polycystins, and their association from 2000 to March 2024. The keywords stated below were used for the article search. We discuss recent advances regarding the implication of Runx2 and polycystins in bone remodeling and regeneration and elaborate on the targeting strategies that may potentially be applied for the treatment of patients with bone loss diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical Biochemistry, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Athens, Greece.
- Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- First Department of Orthopedics, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Athens, Greece.
ORCID-Profile: Antonios N Gargalionis, Christos Adamopoulos, Christos T Vottis, Athanasios G Papavassiliou
Zitieren
APA
Gargalionis, A. N., Adamopoulos, C., Vottis, C. T., Papavassiliou, A. G., & Basdra, E. K. (2024). Runx2 and Polycystins in Bone Mechanotransduction: Challenges for Therapeutic Opportunities. International Journal of Molecular Sciences, 25(10), 5291. https://doi.org/10.3390/ijms25105291
Vancouver
Gargalionis AN, Adamopoulos C, Vottis CT, Papavassiliou AG, Basdra EK. Runx2 and Polycystins in Bone Mechanotransduction: Challenges for Therapeutic Opportunities. International Journal of Molecular Sciences. 2024;25(10):5291. doi:10.3390/ijms25105291
BibTeX
@article{Gargalionis2024,
author = {Gargalionis, Antonios N and Adamopoulos, Christos and Vottis, Christos T and Papavassiliou, Athanasios G and Basdra, Efthimia K},
title = {Runx2 and Polycystins in Bone Mechanotransduction: Challenges for Therapeutic Opportunities},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {10},
pages = {5291},
doi = {10.3390/ijms25105291}
}
EUVIMED